Modeling covalent-modifier drugs.
Awoonor-Williams E, Walsh AG, Rowley CN.
Biochim Biophys Acta Proteins Proteom. 2017 Nov;1865(11 Pt B):1664-1675. doi: 10.1016/j.bbapap.2017.05.009. Epub 2017 May 18.
Signalling mechanisms and cellular functions of SUMO.
Vertegaal ACO.
Nat Rev Mol Cell Biol. 2022 Nov;23(11):715-731. doi: 10.1038/s41580-022-00500-y. Epub 2022 Jun 24.
Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases.
Khalaf K, Tornese P, Cocco A, Albanese A.
Transl Neurodegener. 2022 Jun 4;11(1):33. doi: 10.1186/s40035-022-00307-z.
A Compendium of Genetic Modifiers of Mitochondrial Dysfunction Reveals Intra-organelle Buffering.
To TL, Cuadros AM, Shah H, Hung WHW, Li Y, Kim SH, Rubin DHF, Boe RH, Rath S, Eaton JK, Piccioni F, Goodale A, Kalani Z, Doench JG, Root DE, Schreiber SL, Vafai SB, Mootha VK.
Cell. 2019 Nov 14;179(5):1222-1238.e17. doi: 10.1016/j.cell.2019.10.032.
Introduction to Sumoylation.
Wilson VG.
Adv Exp Med Biol. 2017;963:1-12. doi: 10.1007/978-3-319-50044-7_1.
Chemical Metabolism of Xenobiotics by Gut Microbiota.
Nakov R, Velikova T.
Curr Drug Metab. 2020;21(4):260-269. doi: 10.2174/1389200221666200303113830.
Chemical journey of somatic cells to pluripotency.
Abbey D.
Cell Regen. 2022 Aug 3;11(1):27. doi: 10.1186/s13619-022-00126-7.
Biological, chemical, and biochemical strategies for modifying glycopeptide antibiotics.
Marschall E, Cryle MJ, Tailhades J.
J Biol Chem. 2019 Dec 6;294(49):18769-18783. doi: 10.1074/jbc.REV119.006349. Epub 2019 Oct 31.
Urm1: A Non-Canonical UBL.
Termathe M, Leidel SA.
Biomolecules. 2021 Jan 22;11(2):139. doi: 10.3390/biom11020139.
SUMO proteases: from cellular functions to disease.
Claessens LA, Vertegaal ACO.
Trends Cell Biol. 2024 Nov;34(11):901-912. doi: 10.1016/j.tcb.2024.01.002. Epub 2024 Feb 6.
